UNSPSC 85451503: The diagnosis of follow-up examination after chemotherapy for malignant neoplasm

In this classification, this covers the group of activities that yields a diagnosis of follow-up examination after chemotherapy for malignant neoplasm. Follow-up examination after chemotherapy for malignant neoplasm is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Z08.2.

UNSPSC 85451503, Diagnosis of follow-up examination after chemotherapy for malignant neoplasm, is a Commodity code that state and local health systems use to procure diagnostic imaging and ancillary clinical staffing services supporting post-treatment oncology care and broader health system operations. The code appears in solicitations spanning diagnostic imaging infrastructure (PACS systems with EPIC integration), temporary health professional staffing across multiple clinical specialties (audiology, cardiology, diagnostic imaging, respiratory care, surgical support), and special education contracted services—though the latter represents a categorical mismatch and carries no weight in evaluating activity under the code's nominal scope. State and local health systems are the primary issuing bodies, including county-operated medical centers and health systems procuring multi-year technology implementations and vendor pools for clinical service delivery. San Mateo County Medical Center (SMMC) and Santa Clara County Health System appear as active buyers.

Recent activity concentrates in California, with San Mateo County posting a Diagnostic Imaging PACS RFP (Solicitation 660002526251) due October 21, 2026, calling for enterprise-grade system implementation supporting approximately 78,000 annual studies with 99.9% uptime, EPIC integration, and a 9–12 month deployment; and Santa Clara County Health System establishing a non-exclusive, multiple-award qualified vendor pool (RFSQHHSFY270052) due October 7, 2026 for temporary staffing across thirteen ancillary health professional categories including diagnostic imaging and respiratory care, maintained for up to five years with no guaranteed work volume. Both solicitations reflect state and local procurement patterns of multi-year framework agreements, case-by-case scope negotiation, and vendor qualification-based award vehicles rather than single fixed-scope contracts. Geographic activity under the code's actual scope remains limited to recent California postings; broader state and local activity remains sparse or misaligned with the code's oncology-follow-up diagnostic framing.